Shandong Weigao Group Medical Polymer Co Ltd (SHWGY)
1.87
-0.75
(-28.63%)
USD |
OTCM |
Jun 25, 16:00
Shandong Weigao Group Medical Polymer Enterprise Value: 1.890B for June 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 1.890B |
| June 24, 2024 | 2.747B |
| June 21, 2024 | 2.747B |
| June 20, 2024 | 2.747B |
| June 18, 2024 | 2.747B |
| June 17, 2024 | 2.747B |
| June 14, 2024 | 2.747B |
| June 13, 2024 | 2.747B |
| June 12, 2024 | 2.747B |
| June 11, 2024 | 2.747B |
| June 10, 2024 | 2.747B |
| June 07, 2024 | 2.747B |
| June 06, 2024 | 2.747B |
| June 05, 2024 | 2.747B |
| June 04, 2024 | 2.747B |
| June 03, 2024 | 2.747B |
| May 31, 2024 | 2.747B |
| May 30, 2024 | 2.747B |
| May 29, 2024 | 2.747B |
| May 28, 2024 | 2.747B |
| May 24, 2024 | 2.747B |
| May 23, 2024 | 2.747B |
| May 22, 2024 | 2.747B |
| May 21, 2024 | 2.747B |
| May 20, 2024 | 2.747B |
| Date | Value |
|---|---|
| May 17, 2024 | 2.747B |
| May 16, 2024 | 2.747B |
| May 15, 2024 | 2.747B |
| May 14, 2024 | 2.747B |
| May 13, 2024 | 2.747B |
| May 10, 2024 | 2.747B |
| May 09, 2024 | 2.747B |
| May 08, 2024 | 2.747B |
| May 07, 2024 | 2.747B |
| May 06, 2024 | 2.747B |
| May 03, 2024 | 2.850B |
| May 02, 2024 | 2.850B |
| May 01, 2024 | 2.919B |
| April 30, 2024 | 2.793B |
| April 29, 2024 | 2.547B |
| April 26, 2024 | 2.547B |
| April 25, 2024 | 2.547B |
| April 24, 2024 | 2.547B |
| April 23, 2024 | 2.547B |
| April 22, 2024 | 2.547B |
| April 19, 2024 | 2.547B |
| April 18, 2024 | 2.547B |
| April 17, 2024 | 2.547B |
| April 16, 2024 | 2.547B |
| April 15, 2024 | 2.560B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.890B
Minimum
Jun 25 2024
12.74B
Maximum
Aug 05 2020
6.410B
Average
6.005B
Median
Jul 21 2023
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 47.44M |
| Zai Lab Ltd | 1.226B |
| Adagene Inc | 36.97M |
| LakeShore Biopharma Co Ltd | 95.81M |
Enterprise Value Related Metrics
| Earnings Yield | 13.29% |
| Operating Earnings Yield | 15.28% |
| Normalized Earnings Yield | 13.54 |